CAS 283173-50-2 appears in our catalog under these names: Rucaparib (free base), 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-, 98%, 98%, Rucaparib, Rucaparib, >95% (HPLC), Rucaparib/ 99.89% (existing batch purity). Offered by: GLPBio, Chemat, Chemat Brand, TRC, TargetMol. Available pack sizes: 50mg, 5mg, 100mg, 250mg, 1g, 5g, 10g, on request.
Rucaparib is a member of the class of azepinoindoles that is 1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one carrying additional 4-[(methylamino)methyl]phenyl and fluoro substituents at positions 2 and 8 respectively. It is an inhibitor of poly (ADP-ribose) polymerase and is used (as the camsylate salt) as monotherapy for advanced ovarian cancer and deleterious germline or somatic BRCA mutation. It has a role as an antineoplastic agent and an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor. It is an azepinoindole, a member of caprolactams, an organofluorine compound and a secondary amino compound. It is a conjugate base of a rucaparib(1+).
Source: ChEBI
| Molecular formula | C19H18FN3O |
|---|---|
| Molecular weight | 323.4 g/mol |
| IUPAC name | 6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one |
| InChIKey | HMABYWSNWIZPAG-UHFFFAOYSA-N |
| SMILES | CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2 |
Computed by PubChem (NCBI)